Showing posts with label Women. Show all posts
Showing posts with label Women. Show all posts

Thursday, November 17, 2011

Alarms new drug-resistant strains of gonorrhea



A new strain of gonorrhea sexually transmitted resistant to antibiotics, due to its rapid mutation, an international research has shown.

When analyzing this new gonorrhea strains, called H041, researchers have identified gene mutations that make it resistant to all cephalosporin antibiotic line. This is a group of drugs widely used to treat many different types of infections caused by bacteria. They are very close to the penicillin.

"Ever since antibiotics became the standard treatments for gonorrhea in the 1940s, this bacterium has proven surprisingly resistant to all drugs used to control it."

"Although it is too early to judge whether this new strain has spread or not, but according to historical cases of drug resistance in bacteria, then maybe it will spread quickly, unless there are new drugs and treatment of newly released ".

"The prevention becomes more important, because we know that antibiotics are not always effective. Can affect all ages and everyone should now know how to care their sexual health. "

Anumber of treatments have failed. The worry is that we will find that gonorrhea is becoming more difficult to treat in the next 5 years. In this situation, the best prevention. "

Gonorrhea is one of the sexually transmitted disease most common in the world. Approximately 50% of women infected with gonorrhea have no symptoms. For men, some problems have no symptoms from 2 to 5%.

Once symptoms appear, patients should see a burning sensation during urination and can discharge from the penis. If left untreated, the disease can lead to serious complications and can not be recovered in both men and women.

Monday, February 1, 2010

Parliamentary inquiry into the links between experts, labs and policies in the management of influenza A H1N1? Support the initiative of Senator Autai


Relayed the past several initiatives of Senator Francis Autain, one of the very few French politicians to want to curb corruption Radicarl.net.jpgles excesses of the pharmaceutical industry and the vast network of conflicts of interest that maintained at the expense of the common good of citizens and our health.

We have, however, all elected to this, our men and women in politics: to represent the general interest and not kowtow to the financial strength and courtier of the pharmaceutical lobby group or some private interest whatsoever .
Yet it is clear that the abuses and excesses of the industry are legion, made possible by cronyism with policies that do nothing to fill the legislative vacuum and French law, and therefore to provide means of repression (and deterrence) in the area. Whatever the severity of the health scandal of cocooning, acts under the influence of such political, administrative officer, doctor or expert, you can not see any lawsuit brought by the French public powers. Neither them nor the pharmaceutical industry. And no opportunity for users and their associations have a defense and protection worthy of the name. On the contrary, the prosecution Silencing and other means of intimidation of citizens - to muzzle whistleblowers and any form of citizen expertise - flourish without anyone raises the question of the dangers of this phase any independent source and not interested.

No mechanism of participatory democracy does participation and effective citizen deliberation on political and health issues. No legislative does investigate and severely punish the excesses of industry. No safeguards exist, and there is no curb lobbying, conflicts of interest, revolving doors and other epiphenomena reflecting the same tendency to blithely trampling the interest in the name of profits and stock returns and any other the servants of industry, whether on the benches of political assemblies in health agencies, in medical offices or elsewhere.

It reiterates that Francis Autain merit him the confidence of users. It deserves the widest possible support for his work in public health. Work to which we all can and must participate in their own way, to finally start to clean the stables, to clean up this lifelong infection, this chronic sepsis caused by conflicts of interest whose effects were once again illustrated by fiasco of the influenza A H1N1. Make no mistake about it! What happened there is neither isolated nor unique. But the global dimension openly and media coverage have made this unhealthy situation more easily perceptible to the public.

This scandal makes everyone realize how manufacturers and their servants and political science play with our health for base economic. We should seize this as an opportunity to insist on an urgent and comprehensive reform of the system of expertise and political decision-health as a whole, preferably before public health can collapse. We must demand a radical change and not be lulled by the rocking chairs that are the speeches of mutual congratulation, as understood at the appalling meeting of the High Authority of Health dated December 10, 2009. The promising title, "Expertise and Conflicts of Interest", and timeliness of the issue did not prevent the opinion leaders present to say that everything was going well in the brave new world for conflict of interests ... (See for example the protest of the Citizen Science Foundation cons this amazing break between experts and ordinary people and the dangers it involves, on this and this, for example. The Foundation and the network which ETAL it is more proposals are well supported on these issues to the expertise, lobbying and conflicts of interest in health and in all areas).

François Autain and other senators listed below have filed January 21 a resolution "to create a commission to investigate the role of pharmaceutical companies in the management by the Government of influenza A (H1N1) v". This also means "make a transparency on the data elements issued by governments to experts, their independence and possible implications of possible conflicts of interest in the decision making of government."

Friday, January 15, 2010

Women and men are affected by osteoporosis


Osteoporosis is a disease that affects men and women and is characterized by a descent of bone tissue, generating a deterioration of bone tissue by increasing bone fragility. The most common manifestation is a fracture and the consequences that derive from them.

It is a disease that affects more women than men, mainly to people aged over 50 years.

Two types of osteoporosis exist, the type I associated with menopause and type II age-related, affecting people aged over 70 years.

Some risk factors that predispose to suffer the disease are:

* Being a woman
* Posmenopáusica
* White, thin
* Having suffered a premature menopause
* Not having had children
* Be familiar precedents of osteoporosis
* A lifestyle
* A smoking
* Excessive consumption of alcohol
* Sub calcium intake
* A sedentary lifestyle

The clinical manifestation of this disease is fractures.

In type I: the factor that generates the development of osteoporosis in women still lack of estrogen, while men are not a significant bone loss before age 70.

In type II: the lack of vitamin D.

To diagnose the disease is conducting a study that bears the name of Densitometría dual energy X-ray or computed tomography can also be made.

To prevent it we must have an adequate intake of calcium and vitamin D, avoiding tobacco, alcohol, hormone replacement therapy in women posmenopáusicas and physical activity.